Dr. Sushma Kaul, MD

Dr. Kaul practices at Wynn Hospital in Utica, New York, part of Mohawk Valley Health System.

Dr. Kaul's NPI, 1952317091, was assigned on July 31, 2006. Dr. Kaul holds New York license 189385.

Dr. Kaul's primary practice is Wynn Hospital, at 1656 Champlin Avenue, Utica, NY 13503 in Oneida County. The practice phone is (315) 624-6002.

Dr. Kaul's primary practice is Wynn Hospital in Utica, New York, part of Mohawk Valley Health System. Dr. Kaul is also affiliated with Lewis County General Hospital. The medical group on file is Mohawk Valley Health System. Dmand AI also links Dr. Kaul to 1 more group practice or clinic, named with a free account. Dr. Kaul's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaul practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kaul's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kaul is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Kaul is licensed in New York.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Kaul treats.

CMS data shows 1,229 Medicare services from Dr. Kaul across 13 procedure codes in 2024, for 362 Medicare patients. Medicare paid $107,972 for them.

CMS counts 362 Medicare patients who saw Dr. Kaul in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaul's median patient age at 73, with 60% women.

In 2024, Dr. Kaul wrote 1,827 Medicare Part D claims for 280 patients. 37% of them were for generic drugs. CMS names the drug for 1,725 of them, across 30 drugs with 11 or more claims each, at $1,474,130 in total drug cost. In 2023, CMS named 1,667 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kaul for performance year 2024, reported as part of a group. Dr. Kaul accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaul as offering telehealth.

Dmand AI links 7 papers to Dr. Kaul, published from 2011 to 2021. The most frequent topics are Aorta, Cholesterol and Endothelial Cells. Dr. Kaul's most frequent co-authors are John Christian Densmore, MD, Girija G. Konduri, MD and Adeleye James Afolayan, MD.

CMS Open Payments shows 441 general payments to Dr. Kaul from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,007.

Dr. Kaul is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.